Hensoldt's Half-Year Numbers Reveal a Defense Giant Caught Between Momentum and Money

Hensoldt's H1 2026 shows record order intake and backlog, yet negative free cash flow of €136M sparks valuation debate as shares trade near overbought levels.

The arithmetic of defense contracting can be unforgiving. Hensoldt's first-half figures for 2026 tell a story of spectacular commercial traction — bookings that doubled year-on-year, a backlog stretching past the €10 billion mark — yet the company's cash position tells a rather different tale. The Munich-based sensor specialist booked a negative adjusted free cash flow of €136 million over the period, a number that sits awkwardly alongside the headline growth metrics.

Revenue climbed 23.6 percent to €1.167 billion in the first six months, while the adjusted EBITDA margin ticked up from 11.3 to 11.8 percent. That operating improvement, however, remains thin for a company trading at the valuation multiples Hensoldt currently commands. Management's full-year guidance points to revenue of roughly €2.75 billion and an EBITDA margin between 18.5 and 19.0 percent — a substantial jump from the half-year run-rate that implies considerable operational acceleration in the back half of the year.

The order intake, at €2.81 billion, came in at exactly double the €1.41 billion recorded in the same period a year earlier. The order book expanded 46.5 percent to €10.36 billion, giving the company a multi-year visibility that most industrial peers would envy. Yet the cash outflow raises a pointed question: how quickly can those orders be converted into something resembling financial substance?

A Valuation Debate Splits the Analyst Community

The share price, hovering around €91.50, has climbed roughly 25 percent over the past month and nearly a quarter since the start of the year. That rally has pushed the stock's valuation to levels that at least one research house finds indefensible. Analysts at mwb research maintain a sell recommendation with a price target of €62 — implying a downside of roughly a third from current levels. The consensus price-to-earnings ratio for the current fiscal year stands at 46, a multiple that leaves little room for operational stumbles.

Institutional money, meanwhile, appears to be voting with its feet in the opposite direction. BlackRock disclosed on August 11 that it had raised its stake to 4.91 percent as of August 5, a move that helped lift the shares 4.29 percent in a single week. The accumulation reads less as a short-term trading call and more as a bet on Hensoldt's strategic position within the European defense industrial base — a position that looks increasingly valuable as governments across the continent reassess their security spending.

Technical Pressure Builds Beneath the Surface

Chart technicians would flag the stock as running hot. The relative strength index sits at 69.6, just shy of the 70 threshold that conventionally signals overbought conditions. The share price trades 18.34 percent above its 50-day moving average, a stretched distance that historically increases the odds of a pullback. Yet the stock remains 22.31 percent below its October 2025 high — a gap that suggests the market has priced in substantial future growth without the shares having reclaimed their previous peak.

Regulatory Clouds and the Cash Conversion Test

Adding to the uncertainty are unconfirmed reports of regulatory friction in Germany that could slow both Hensoldt and drone specialist DroneShield, while competitor Volatus Aerospace reportedly stands to benefit from a potential order surge. The reports lack specifics on affected projects or timelines, leaving investors to weigh vague warnings against the empirical evidence of a doubling order intake. The tension between those two signals — bureaucratic drag versus robust demand for sensor and defense technology — is unlikely to resolve until the next quarterly figures arrive.

For shareholders, the central tension is straightforward. The order book, up nearly half within a year, provides a solid foundation for medium-term revenue. But at a market capitalization of €10.48 billion, with annualized volatility around 49 percent, the stock demands that management convert its backlog into positive cash flow with visible margin expansion. The company's cash position will need to improve markedly in the coming quarters to justify the premium the market currently assigns. Until then, the gap between the optimists and the skeptics — roughly €30 per share — reflects a genuine disagreement about whether Hensoldt's growth story can translate into financial performance worthy of its valuation.